HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity
about
Experimental models of hepatotoxicity related to acute liver failureAcetaminophen-induced Liver Injury: from Animal Models to HumansPathophysiological significance of c-jun N-terminal kinase in acetaminophen hepatotoxicityPathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation PlansOxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potentialA cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophenDual role of acetaminophen in promoting hepatoma cell apoptosis and kidney fibroblast proliferation.The Impact of Sterile Inflammation in Acute Liver Injury.Mechanisms of acetaminophen hepatotoxicity and their translation to the human pathophysiology.Acetaminophen and NAPQI are toxic to auditory cells via oxidative and endoplasmic reticulum stress-dependent pathways.High-throughput and combinatorial gene expression on a chip for metabolism-induced toxicology screening.Mechanisms of acetaminophen-induced cell death in primary human hepatocytes.Determination of drug toxicity using 3D spheroids constructed from an immortal human hepatocyte cell line.Tolerance to acetaminophen hepatotoxicity in the mouse model of autoprotection is associated with induction of flavin-containing monooxygenase-3 (FMO3) in hepatocytes.Current issues with acetaminophen hepatotoxicity--a clinically relevant model to test the efficacy of natural products.Lower susceptibility of female mice to acetaminophen hepatotoxicity: Role of mitochondrial glutathione, oxidant stress and c-jun N-terminal kinase.The role of the c-Jun N-terminal kinases 1/2 and receptor-interacting protein kinase 3 in furosemide-induced liver injuryInhibitor of apoptosis signal-regulating kinase 1 protects against acetaminophen-induced liver injury.Effect of bile duct ligation on bile acid composition in mouse serum and liverConfirming the Causative Role of Acetaminophen in Indeterminate Acute Liver Failure Using Acetaminophen-Cysteine Adducts.Prolonged Acetaminophen-Protein Adduct Elimination During Renal Failure, Lack of Adduct Removal by Hemodiafiltration, and Urinary Adduct Concentrations After Acetaminophen Overdose.MicroRNAs as Signaling Mediators and Biomarkers of Drug- and Chemical-Induced Liver Injury.Acetaminophen induces JNK/p38 signaling and activates the caspase-9-3-dependent cell death pathway in human mesenchymal stem cells.The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation.Acetaminophen: Dose-Dependent Drug Hepatotoxicity and Acute Liver Failure in Patients.Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injuryTime course of acetaminophen-protein adducts and acetaminophen metabolites in circulation of overdose patients and in HepaRG cells.Mitochondrial protein adducts formation and mitochondrial dysfunction during N-acetyl-m-aminophenol (AMAP)-induced hepatotoxicity in primary human hepatocytesAcetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity.Acetaminophen cytotoxicity is ameliorated in a human liver organotypic co-culture modelGeographic variation in utilization of sentinel lymph node biopsy for intermediate thickness cutaneous melanomaLysosomal instability and cathepsin B release during acetaminophen hepatotoxicity.Lack of Direct Cytotoxicity of Extracellular ATP against Hepatocytes: Role in the Mechanism of Acetaminophen HepatotoxicityBile Acid-Induced Toxicity in HepaRG Cells Recapitulates the Response in Primary Human HepatocytesAcetaminophen-induced acute liver injury in HCV transgenic mice.Purinergic receptor antagonist A438079 protects against acetaminophen-induced liver injury by inhibiting p450 isoenzymes, not by inflammasome activationParacetamol (acetaminophen) protein adduct concentrations during therapeutic dosing.Models of drug-induced liver injury for evaluation of phytotherapeutics and other natural products.Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications.
P2860
Q26775293-4B97E3C0-3B76-430B-8B5E-4CB34B2CFE7EQ26781944-C725403D-423F-4DD3-8B1B-1CB5E932BB5FQ26799194-B7D30036-3705-4F21-B7B5-5E74EE1A0F01Q27690772-055489B7-15B4-4341-B6C9-B7D99CC29378Q28075991-0ADFCB33-BA68-4ACC-87AE-4B9C29192B9DQ28077959-C84C59B9-3F92-4854-AD63-682C839FEDB6Q28396747-C1DC7FD0-646A-4518-8A17-3BCBC73B2504Q33747703-E83FEB34-40D5-4A48-99E7-0B7B769691DBQ33847610-7505CFA9-06C2-4F94-9FF3-BFD1E7AA1928Q33848167-BC489E3A-3C09-41E5-8E4A-10B8FF7596CBQ33856157-F0909EC5-634A-49FF-9E09-F278D5BB0AFDQ34044936-438AF589-7706-4303-9721-B119CB86086BQ34225946-F76F7D87-DC6E-4B78-808E-8F765D42F30DQ34264069-D3B21A08-567D-4DF4-B35B-579B76DDD26FQ34737067-37CB69CB-DD62-4E8D-A25F-3ACAE8B0E098Q34792136-0B02416C-1EFC-4229-911F-BEF609EBFE10Q35185719-EA06A9D5-0444-4B5D-830F-C6280997C836Q35642533-00CF99DF-7B01-437E-9D1F-25FC20A179DBQ35648831-5977DC23-67D4-4AA1-BBE8-C3F7E30BAB38Q35687185-20F6A23E-1CF5-45FD-8613-17CE267809C8Q35749121-59B143E9-9E3B-49A9-BC11-04A1F266BCA9Q35749131-8D9E1EB7-438B-488C-90E8-A5A4CC877421Q35750622-2A0882AE-6D7F-4FE3-BC70-4ED66526D971Q35849976-312977E7-273F-4AB2-B76E-628FD072E27FQ35858082-A3E0DB82-2E37-4907-953B-AA5ACD23D31EQ35903687-79EC254E-838B-4989-9CC3-C8B0444ADD71Q35969312-B8FAF86C-466F-4693-948D-BB55F75E27C6Q36005892-8F1C1C77-0E20-4F58-BF7D-26C39EEF50AFQ36296762-3A37F439-5800-46A4-9F84-85712DDE0B62Q36339274-2ADDD251-4628-4D24-B336-0F82FA5D546AQ36343336-0D0447CD-99CE-4F91-9D9B-CDA795004E64Q36368420-0A1F67FF-19A4-4807-AC38-9DC06C4DB9B0Q36409780-F3DF94DA-E39B-4BCE-B4E6-C7CF796FB548Q36412669-349AD79D-07C0-4DD1-991D-D2E9E05BD6A8Q36464118-24012E38-9000-49B6-9355-04F191468D5DQ36501177-9D35F0C1-D309-4DA6-AA5A-9174F9A16DF9Q36509045-62B87C5F-FD8C-4BBC-A2C2-E8C4680CB26DQ36618136-EF2FDA0D-C083-4E8A-932B-FBADEBBF400AQ36718265-568CB3EC-F1EE-4ED2-961E-D303F9790F8EQ36844150-8F2F029F-E848-4366-824E-71272D411642
P2860
HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity
@ast
HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity
@en
HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity
@nl
type
label
HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity
@ast
HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity
@en
HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity
@nl
prefLabel
HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity
@ast
HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity
@en
HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity
@nl
P2093
P2860
P356
P1433
P1476
HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity
@en
P2093
Anup Ramachandran
Douglas E Rollins
Gordon J Murray
Hartmut Jaeschke
Hui-Min Yan
Mitchell R McGill
P2860
P304
P356
10.1002/HEP.24132
P407
P577
2011-02-11T00:00:00Z